7 news items
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for Incubation of Early Drug Discovery Programs
TAK
22 Apr 24
companies, and start-up companies across Japan to enable access to potentially
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
TAK
18 Apr 24
/entyvio-epar-product-information_en.pdf. Last updated: April 2023. Last accessed: January 2024
Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE
TAK
27 Mar 24
. Last accessed Nov 2023
2- Ng SC
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders, Financial Terms Undisclosed
CNTG
TAK
19 Mar 24
, CENTOGENE will continue to provide Takeda with access to diagnostic testing for patients around the world. The agreement was established to enhance
Takeda And Biological E. Limited Enter Strategic Partnership To Accelerate Access To Dengue Vaccine In Endemic Areas
TAK
27 Feb 24
hmod234
TAK
26 Feb 24
) and Biological E. Limited (BE), a leading India-based Vaccines and Pharmaceutical Company, today announced a strategic partnership to accelerate access
u5y8bnoyu2yzrl1soy6mtk62fv0cnhp
TAK
26 Feb 24
face numerous challenges – from delayed diagnosis and access to treatment, to facing stigma, isolation and even discrimination
- Prev
- 1
- Next